Inge Marie Svane

Inge Marie Svane

Clinical Professor

Member of:

  • Clinical Oncology

ORCID: 0000-0002-9451-6037

Publication year:
All
161 - 170 out of 274Page size: 10
Sort by: Title
  1. Published

    Long-term follow-up of anti-PD-1 naïve patients with metastatic melanoma treated with IDO/PD-L1 targeting peptide vaccine and nivolumab

    Lorentzen, C. L., Kjeldsen, J. W., Ehrnrooth, E., Andersen, M. H. & Svane, Inge Marie, 2023, In: Journal for ImmunoTherapy of Cancer. 11, 5, 10 p., e006755.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Low-dose prednisolone in first-line docetaxel for patients with metastatic castration-resistant prostate cancer: is there a clinical benefit?

    Kongsted, P., Svane, Inge Marie, Lindberg, H., Daugaard, G. & Sengeløv, L., Nov 2015, In: Urologic Oncology: Seminars and Original Investigations. 33, 11, p. 494.e15-20

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Lynch syndrome-associated epithelial ovarian cancer and its immunological profile

    Rasmussen, M., Lim, K., Rambech, E., Andersen, Mads Hald, Svane, Inge Marie, Andersen, Ove, Jensen, L. H., Nilbert, Mef Christina & Therkildsen, C., 2021, In: Gynecologic Oncology. 162, 3, p. 686-693

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    MERTK Acts as a costimulatory receptor on human cd8 t cells

    Peeters, M. J. W., Dulkeviciute, D., Draghi, A., Ritter, C., Rahbech, A., Skadborg, S. K., Seremet, T., Simoes, A. M. C., Martinenaite, E., Halldorsdottir, H. R., Andersen, Mads Hald, Olofsson, G. H., Svane, Inge Marie, Rasmussen, Lene Juel, Met, Özcan, Becker, J. C., dqp123, dqp123, Desler, Claus & Straten, P. T., 2019, In: Cancer Immunology Research. 7, 9, p. 1472-1484 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Manufacture of adoptive cell therapies at academic cancer centers: scientific, safety and regulatory challenges

    Saini, K. S., Svane, Inge Marie, Juan, M., Barlesi, F. & André, F., 2022, In: Annals of Oncology. 33, 1, p. 6-12 7 p.

    Research output: Contribution to journal › Editorial › Research › peer-review

  6. Published

    Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial

    Ellebaek, E., Engell-Noerregaard, L., Iversen, T. Z., Moerch Froesig, T., Munir, S., Hadrup, S. R., Andersen, M. H. & Svane, Inge Marie, 2012, In: Cancer Immunology, Immunotherapy. 61, 10, p. 1791-1804 14 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Methods to Improve Adoptive T-Cell Therapy for Melanoma: IFN-γ Enhances Anticancer Responses of Cell Products for Infusion

    Donia, M., Hansen, M., Sendrup, S. L., Iversen, T. Z., Ellebæk, E., Andersen, M. H., Straten, P. T. & Svane, Inge Marie, 2013, In: Journal of Investigative Dermatology. 133, 2, p. 545-52 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    More tricks with tetramers: a practical guide to staining T cells with peptide-MHC multimers

    Dolton, G., Tungatt, K., Lloyd, A., Bianchi, V., Theaker, S. M., Trimby, A., Holland, C. J., Donia, M., Godkin, A. J., Cole, D. K., Straten, P. T., Peakman, M., Svane, Inge Marie & Sewell, A. K., Sep 2015, In: Immunology. 146, 1, p. 11-22 12 p.

    Research output: Contribution to journal › Review › Research › peer-review

  9. Published

    Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

    Lauss, M., dqp123, dqp123, Harbst, K., Andersen, R., Mitra, S., Rosengren, F., Salim, M., Vallon-Christersson, J., Törngren, T., Kvist, A., Ringnér, M., Svane, Inge Marie & Jönsson, G., 2017, In: Nature Communications. 8, 11 p., 1738.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation

    Duraiswamy, J., Turrini, R., Minasyan, A., Barras, D., Crespo, I., Grimm, A. J., Casado, J., Genolet, R., Benedetti, F., Wicky, A., Ioannidou, K., Castro, W., Neal, C., Moriot, A., Renaud-Tissot, S., Anstett, V., Fahr, N., Tanyi, J. L., Eiva, M. A., Jacobson, C. A. & 16 others, Montone, K. T., Westergaard, M. C. W., Svane, Inge Marie, Kandalaft, L. E., Delorenzi, M., Sorger, P. K., Färkkilä, A., Michielin, O., Zoete, V., Carmona, S. J., Foukas, P. G., Powell, D. J., Rusakiewicz, S., Doucey, M. A., Dangaj Laniti, D. & Coukos, G., 2021, In: Cancer Cell. 39, 12, p. 1623-1642.e20

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1...13 14 15 16 17 18 19 20 ...28 Next

ID: 4054758